We are live on !
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
Turnover
12.28%
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.08%
10 Year Est. Return
+563.15%
AUM
$253M
AUM Growth
-$1.03M
(-0.41%)
Cap. Flow
-$12.7M
Cap. Flow % of AUM
Cap. Flow %
-5%
Top 10 Holdings %
Top 10 Hldgs %
39.44%
Holding
60
New
1
Increased
16
Reduced
4
Closed
3
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$4.61M |
| 2 |
Analog Devices
ADI
|
+$261K |
| 3 |
Novartis
NVS
|
+$200K |
| 4 |
Nike
NKE
|
+$184K |
| 5 |
Johnson & Johnson
JNJ
|
+$171K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$4.72M |
| 2 |
Pfizer
PFE
|
+$3.95M |
| 3 |
Procter & Gamble
PG
|
+$2.7M |
| 4 |
Kroger
KR
|
+$2.64M |
| 5 |
ExxonMobil
XOM
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.43% |
| 2 | Industrials | 20.92% |
| 3 | Technology | 17.8% |
| 4 | Consumer Staples | 9.41% |
| 5 | Communication Services | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CDK
51
DELISTED
CDK Global, Inc.
CDK
| $772K | 0.3% |
10,833
| – | – |
2015 Q4
8 quarters
|
|
|
52
Novartis
NVS
$286B
| $652K | 0.26% |
8,666
+2,651
| +44% | +$200K |
2015 Q4
8 quarters
|
|
53
DELISTED
Encore Wire Corp
WIRE
| $632K | 0.25% |
13,000
| – | – |
2015 Q4
8 quarters
|
|
54
Canadian National Railway
CNI
$73.6B
| $588K | 0.23% |
7,125
+1,725
| +32% | +$139K |
2015 Q4
8 quarters
|
|
55
Coca-Cola
KO
$404B
| $373K | 0.15% |
8,131
| – | – |
2015 Q4
8 quarters
|
|
56
Chevron
CVX
$441B
| $309K | 0.12% |
2,472
| – | – |
2015 Q4
8 quarters
|
|
57
iShares Core S&P 500 ETF
IVV
$880B
| $215K | 0.08% |
800
| – | – |
2017 Q3
1 quarter
|
|
|
58
Johnson Controls International
JCI
$88.1B
| – | – |
-117,279
| Closed | -$4.72M | – |
|
59
DELISTED
Kellanova
K
| – | – |
-31,950
| Closed | -$1.87M | – |
|
|
60
Kroger
KR
$37.6B
| – | – |
-131,705
| Closed | -$2.64M | – |
|
Similar funds
Chad R. Baker's Q4 2017 Portfolio in Review
As of Q4 2017, Chad R. Baker held 60 positions worth $253M, down 0.41% from $254M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Chad R. Baker withdrew a net $12.7M in Q4 2017, closing 3 positions and reducing 4 holdings. Its most notable exit was Johnson Controls International, an estimated $4.72M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.
Against the trend, Chad R. Baker opened a new position in Broadcom worth $4.56M.
- Chad R. Baker's largest Q4 2017 buy was Broadcom: 177,400 shares worth $4.56M.
- Chad R. Baker added most to Analog Devices in Q4 2017, an estimated $261K increase.
- Chad R. Baker's biggest Q4 2017 reduction was Pfizer, cutting an estimated $3.95M.
- Chad R. Baker fully exited Johnson Controls International in Q4 2017, selling an estimated $4.72M.
- Chad R. Baker's ten largest holdings make up 39% of its $253M portfolio in Q4 2017.
- Chad R. Baker opened 1 new position and closed 3 in Q4 2017.
- Chad R. Baker's portfolio value fell 0.41% quarter-over-quarter to $253M.
Based on Chad R. Baker's 13F filing for Q4 2017, filed 13 Feb 2018.